Benchmark Co. Gives Buy Rating to Synergetics Usa Incorporated (SURG)

By admin | 6 years ago

Synergetics Usa Incorporated (NASDAQ: SURG)‘s stock had its “buy” rating restated by equities researchers at Benchmark Co. in a report issued on Monday.

Synergetics Usa Incorporated traded up 3.65% on Monday, hitting $3.98. Synergetics Usa Incorporated has a 52-week low of $3.30 and a 52-week high of $7.55. The company has a market cap of $100.2 million and a price-to-earnings ratio of 15.18.

Synergetics Usa Incorporated last posted its quarterly earnings results on Monday, March 12nd. The company reported $0.07 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.07. Synergetics Usa Incorporated’s revenue was up 12.9% compared to the same quarter last year. Analysts expect that Synergetics Usa Incorporated will post $0.09 EPS next quarter.

Separately, analysts at Wunderlich reiterated a “buy” rating on shares of Synergetics Usa Incorporated in a research note to investors on Monday, March 26th. They now have a $8.00 price target on the stock.

Synergetics USA, Inc. (Synergetics USA) is a medical device company. It is a supplier of precision microsurgical devices.

About the author